PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases

By: Investing.com

Sep 18 2024
86
340 Views

PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases — PharmaDrug's Sairiyo Therapuet

Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, developmen… [+14549 chars]

Howard W. Robin Sells 14,881 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Laverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule

Warning: September Asthma Spike Ahead

Brokerages Set Nektar Therapeutics (NASDAQ:NKTR) Price Target at $1.50

PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases

Smart ways to use turmeric beyond cooking

10 simple habits that help improve eyesight naturally

Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care

Share this page

Guest Posts by Easy Branches

FERRETTI GROUP SCORES A HUGE SUCCESS AT THE WORLD

CRN DESIGN EXCELLENCE AT THE MONACO YACHT SHOW 202

Unlocking Market Trends: How Candlestick Patterns

Britain's Most Prominent Royal Jewels

all our websites

PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases

Related

Share this page